article thumbnail

As Chemotherapy Drug Shortage Continues, Unimaginable Decisions and Lacking Accountability Reign

Pharmacy Times

Treatment providers have been forced to adapt and make potentially life-altering decisions for patients due to persistent chemotherapy drug shortages, all while solutions from the FDA and drug manufacturers remain scant.

article thumbnail

Atorvastatin shown to reduce cardiac dysfunction in anthracycline-based chemotherapy

Hospital Pharmacy Europe

The use of atorvastatin prior to anthracycline-based chemotherapy in lymphoma patients reduces the subsequent development of cardiac dysfunction, according to the findings of a randomised trial. The post Atorvastatin shown to reduce cardiac dysfunction in anthracycline-based chemotherapy appeared first on Hospital Pharmacy Europe.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

High BMI in Breast Cancer Patients Linked With Increased Cardiotoxicity During Chemotherapy

Drug Topics

A recent study being presented at the American College of Cardiology Latin America 2023 conference found the prevalence of cardiotoxicity among patients with breast cancer undergoing chemotherapy was 11.94%.

article thumbnail

Pembrolizumab plus chemotherapy improves overall survival compared to chemotherapy alone in advanced biliary tract cancer

Hospital Pharmacy Europe

Using pembrolizumab plus gemcitabine and cisplatin improves overall survival compared to chemotherapy alone in advanced biliary tract cancer Patients with biliary tract cancers invariably present at a late stage when curative surgery is not possible. Adults were randomised 1:1 to pembrolizumab plus chemotherapy or placebo and chemotherapy.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This new guidance will clearly impact the clinical research field, but how?

article thumbnail

Novel device opens blood-brain barrier to deliver chemotherapy

European Pharmaceutical Review

The blood-brain barrier (BBB) in glioblastoma patients was opened temporarily using a novel, skull-implantable ultrasound device to deliver chemotherapy to the brain in a first in-human trial. Two chemotherapy drugs , paclitaxel and carboplatin were injected intravenously during the four-minute procedure.

article thumbnail

Chemotherapy prescribing habits for stage 3 colon cancer changed following IDEA study

Hospital Pharmacy Europe

A significant and increasing trend towards the use of a three-month rather than six-month adjuvant chemotherapy regime in stage 3 colon cancer has been observed following publications from the IDEA collaboration abstract. In addition, CAPOX prescribing also significantly increased from 14% to 48% (p <0.001).